ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 638

Estrogen-Induced STAT1 and STAT4 Expression Is Estrogen Receptor α Dependent and IFNα Independent: A Novel Mechanism For Sex-Bias In Systemic Lupus Erythematosus Pathogenesis?

Nicholas A. Young1, Giancarlo R. Valiente2, Lai-Chu Wu1, Michael Bruss3, Craig Burd4 and Wael N. Jarjour5, 1Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 2Medical Scientist Training Program, The Ohio State University College of Medicine, Columbus, OH, 3Division of Rheumatology and Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, 4Molecular Genetics, The Ohio State University Wexner Medical Center, Columbus, OH, 5Dept of Rheumatology/Medicine, The Ohio State University Wexner Medical Center, Columbus, OH

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Auto-immunity, hormones, Inflammation, systemic lupus erythematosus (SLE) and toll-like receptors

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis: Mechanisms and Biomarkers

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Systemic Lupus Erythematosus (SLE) is a devastating multi-organ autoimmune disease displaying an overwhelming female predilection. Estrogen (E2) influences gene expression by binding to estrogen receptors (ERα and ERβ) and a role for E2 has been proposed in SLE pathogenesis. Further, E2 has been shown to regulate Signal Transducer and Activator of Transcription (STAT) 1 and STAT4 function. Toll-Like Receptor 8 (TLR8) has also been implicated in SLE and is a potent inflammatory mediator.  The results of this study demonstrate the E2-mediated induction of STAT1 and STAT4 for the first time in primary human peripheral blood mononuclear cells (PBMCs) and mechanistically characterize the pathway that is operative in this induction.

Methods:

PBMCs isolated from SLE patients and healthy controls were treated with a physiological dose of E2.  Putative estrogen response elements (EREs) in the human genome were identified from ChIP-seq data of MCF-7 cells stimulated with E2 for one hour.  Radio-labeled probes corresponding to STAT1 DNA binding regions were used in EMSA analysis to examine DNA-protein complex formation in a human monocytic cell line (THP-1).  In the presence of E2, siRNA was used to block ERα or STAT1 expression in THP-1 cells lacking detectable IFNα expression.

Results:

Expression of STAT1 and STAT4 was elevated in PBMCs of SLE patients relative to age and sex-matched healthy controls. Moreover, E2 stimulation of freshly isolated human PBMCs significantly induced STAT1 and STAT4 expression.  Given that we have previously observed that TLR8 expression is higher in SLE and induced with E2 treatment, a bona fide STAT1 binding region located 24 kb from the 3’ end of the TRL8 gene was used in EMSA analysis to show that enhanced DNA-protein complex formation was induced by E2 stimulation.  Interestingly, STAT1 is located next to STAT4 and ChIP-seq data of cells stimulated with E2 revealed an intragenic ERE binding peak within the STAT1 locus, which suggests that E2 may be promoting the expression of both genes through this response element.  Using siRNA to explore E2 induction of STAT1 mechanistically, we demonstrate that this response is mediated through ERα.  Furthermore, siRNA blocking STAT1 significantly reduced TLR8 induction with E2 stimulation.

Conclusion:

E2 can stimulate the expression of STAT1 and STAT4 in PBMCs and potentially contribute to the pathogenesis observed in SLE due to their potent signal transducing effects over the immune system. STAT1 promotes TLR8 expression after E2 stimulation and an ERE near both STAT1 and STAT4 has been identified through ChIP analysis.  The identification of molecular targets to inhibit the TLR8 inflammatory pathway presents a significant therapeutic opportunity.  Collectively, our results indicate that STAT1 and STAT4 may contribute to the E2-mediated sex-bias observed in autoimmunity through ERα signaling and may potentially be ideal targets in future therapy to treat SLE.


Disclosure:

N. A. Young,
None;

G. R. Valiente,
None;

L. C. Wu,
None;

M. Bruss,
None;

C. Burd,
None;

W. N. Jarjour,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/estrogen-induced-stat1-and-stat4-expression-is-estrogen-receptor-%ce%b1-dependent-and-ifn%ce%b1-independent-a-novel-mechanism-for-sex-bias-in-systemic-lupus-erythematosus-pathogenesis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology